Eli Lilly and Company Seeks Approval for Cymbalta in Fibromyalgia

August 21, 2007 |

1 min read

BOSTON, Aug 21 (Reuters) - Eli Lilly and Co. (LLY.N: Quote, Profile, Research) said on Tuesday it has filed for U.S. approval to sell its antidepressant Cymbalta as a treatment for the pain condition fibromyalgia.

Regulatory

Eli Lilly and Company

MORE ON THIS TOPIC

Donald Trump sits at a desk holding up a piece of paper he just signed while a crowd of people applauds

Government

Trump’s Tax Law Restores Orphan Drug Exemptions, Cuts Medicaid, Threatens 340B Program and Gives PBMs a Pass

July 8, 2025

·

3 min read

·

Tristan Manalac

Health and Human Services Secretary Robert F. Kennedy Jr. makes remarks at an event announcing the MAHA (Make America Healthy Again) Commission, Thursday, May 22, 2025, in the East Room of the White House. (Official White House Photo by Joyce N. Boghosian)

Legal

Medical Groups Sue RFK Jr. Over ‘Baseless and Uninformed’ Changes to COVID-19 Vaccine Policy

July 8, 2025

·

2 min read

·

Tristan Manalac

Success to win in business competition, overcome obstacles or motivation to solve problem and lead company achievement concept, confident businessman leader jump high over 3 hurdles to be winner.

Approvals

KalVista Wins OK for First On-Demand Hereditary Angioedema Pill

July 7, 2025

·

2 min read

·

Tristan Manalac

Entrance to the U.S. Department of Health and Human Services in Washington, DC

Layoffs

HHS Cuts and Rehires by the Numbers: What We Know About Kennedy’s Overhaul

July 7, 2025

·

3 min read

·

Tristan Manalac